Betta Pharmaceuticals Co (SZSE:300558) EV-to-Revenue : 7.14 (As of May. 16, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Betta Pharmaceuticals Co's enterprise value is ¥19,007 Mil. Betta Pharmaceuticals Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,660 Mil. Therefore, Betta Pharmaceuticals Co's EV-to-Revenue for today is 7.14.

The historical rank and industry rank for Betta Pharmaceuticals Co's EV-to-Revenue or its related term are showing as below:

SZSE:300558' s EV-to-Revenue Range Over the Past 10 Years
Min: 6.54 Med: 16.42 Max: 37.23
Current: 7.14

During the past 13 years, the highest EV-to-Revenue of Betta Pharmaceuticals Co was 37.23. The lowest was 6.54. And the median was 16.42.

SZSE:300558's EV-to-Revenue is ranked worse than
83.72% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.395 vs SZSE:300558: 7.14

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-16), Betta Pharmaceuticals Co's stock price is ¥40.51. Betta Pharmaceuticals Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥6.27. Therefore, Betta Pharmaceuticals Co's PS Ratio for today is 6.47.

Betta Pharmaceuticals Co EV-to-Revenue Historical Data

The historical data trend for Betta Pharmaceuticals Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co EV-to-Revenue Chart

Betta Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

17.04

23.01

14.38

9.14

9.51

Betta Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															11.22	8.92	9.35	9.51	7.20

Competitive Comparison of Betta Pharmaceuticals Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Betta Pharmaceuticals Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's EV-to-Revenue falls into.

Betta Pharmaceuticals Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Betta Pharmaceuticals Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	19006.659	/	2660.352
	=	7.14

Betta Pharmaceuticals Co's current Enterprise Value is ¥19,007 Mil.
Betta Pharmaceuticals Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,660 Mil.

Betta Pharmaceuticals Co (SZSE:300558) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Betta Pharmaceuticals Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	40.51	/	6.265
	=	6.47

Betta Pharmaceuticals Co's share price for today is ¥40.51.
Betta Pharmaceuticals Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.27.

Betta Pharmaceuticals Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.bettapharma.com

Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines